Search Results 8171-8180 of 38456 for oral

1. Surgery - Doctors - Mayo Clinic

   Christopher F. Viozzi, M.D., D.D.S.. Oral and Maxillofacial Surgeon. Rochester, MN ...

2. Sleep disorders - Doctors and departments - Mayo Clinic

   Davis, M.D.. Dermatologist. Rochester, MN. Areas of focus: Wound care, Patch test, Chronic hives, Erythromelalgia, Oral lichen planus, Dermatitis, Mixed ...

3. Immunogenetics of COVID-19 Immune Response - Mayo Clinic

   Preventative use of antibiotics (i.e. oral surgery) is not an exclusion criterion. Diagnosis of a cognitive disorder (e.g., Alzheimer's, Dementia). Anemia ...

4. Diverticulitis - Diagnosis and treatment - Mayo Clinic

   This common colon disease develops when small pouches form in the colon wall and become inflamed, causing pain, fever and abnormal stool function.

5. Diabetic nephropathy (kidney disease) - Doctors and departments - Mayo Clinic

   Research at Mayo Clinic in diabetic nephropathy includes developing new diagnostic and treatment tools, such as oral medicines that may help stop or delay ...

6. Rituximab, Bendamustine Hydrochloride, and Lenalidomide in Treating Patients with Refractory or Relapsed Indolent Non-Hodgkin Lymphoma - Mayo Clinic

   Patients unable to take any prophylaxis are not eligible. Life expectancy ≥6 months; Ability to swallow oral medications. Exclusion Criteria: This study ...

7. A Study to Assess the Safety and Tolerability of Atezolizumab in Combination With Other Immune-Modulating Therapies in Participants With Locally Advanced or Metastatic Solid Tumors - Mayo Clinic

   ... oral contraceptives; (2) tyrosine kinase inhibitors (TKIs) that have been discontinued greater than (>) 7 days prior to Cycle 1, Day 1, baseline scans must ...

8. Nab-paclitaxel and Gemcitabine vs Gemcitabine Alone as Adjuvant Therapy for Patients with Resected Pancreatic Cancer (the "Apact" Study) - Mayo Clinic

   ... oral agent hypothesized to inhibit multiple oncogenic pathways. In this article, we describe the design and rationale for the CanStem111P clinical trial, a ...

9. Genetic Analysis in Blood and Tumor Samples From Patients With Advanced or Metastatic Estrogen Receptor Positive and HER2 Negative Breast Cancer Receiving Palbociclib and Endocrine Therapy - Mayo Clinic

   Able to swallow oral formulation of drugs. Signed and dated informed consent document for study participation. Willing to submit tissue, blood, stool ...

10. A Study of ASP8273 versus Erlotinib or Gefitinib as First-Line Treatment for Patients with Stage IIIB/IV Non-Small Cell Lung Cancer - Mayo Clinic

    Has difficulty taking oral medication or any digestive tract dysfunction or inflammatory bowel disease that would interfere with the intestinal absorption of ...